Loading news...
DNB Asset Management AS trimmed its position in shares of IQVIA Holdings Inc. (NYSE: IQV) by 9.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 81,265 shares of the medical research company's stock after selling 8,000 shares during the quarter. DNB
IQVIA Holdings delivered strong Q4 and full-year 2025 results, confirming its leadership in data, analytics, and clinical execution. Despite macro headwinds and cautious biotech spending, IQV maintained robust profitability, near-100% cash conversion, and expanded its $32.7B backlog. EPS guidance for 2026 was below consensus, triggering a selloff, but I remain bullish due to durable bookings, backlog, and elite financial metrics.
Artisan Partners Limited Partnership grew its stake in IQVIA Holdings Inc. (NYSE: IQV) by 4.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,433,957 shares of the medical research company's stock after buying an additional 161,085
IQVIA Holdings Inc. (IQV) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
Dana Investment Advisors Inc. increased its stake in shares of IQVIA Holdings Inc. (NYSE: IQV) by 18.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 160,057 shares of the medical research company's stock after buying an additional 24,854 shares during the
EDENTREE ASSET MANAGEMENT Ltd purchased a new position in IQVIA Holdings Inc. (NYSE: IQV) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 38,800 shares of the medical research company's stock, valued at approximately $7,368,000. IQVIA makes up about 1.8%
Citigroup Inc. raised its position in shares of IQVIA Holdings Inc. (NYSE: IQV) by 108.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 915,183 shares of the medical research company's stock after acquiring an additional 475,557 shares during the
AMG National Trust Bank purchased a new position in shares of IQVIA Holdings Inc. (NYSE: IQV) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 19,549 shares of the medical research company's stock, valued at approximately $3,713,000. Several other hedge funds and
PNC Financial Services Group Inc. lessened its stake in IQVIA Holdings Inc. (NYSE: IQV) by 6.4% in the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 46,537 shares of the medical research company's stock after selling 3,173 shares during the quarter. PNC Financial
Explore IQVIA's (IQV) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Cibc World Market Inc. boosted its stake in shares of IQVIA Holdings Inc. (NYSE: IQV) by 50.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,795 shares of the medical research company's stock after buying an additional
Investors need to pay close attention to IQVIA stock based on the movements in the options market lately.
Oakmark Global All Cap Strategy portfolio's return was 4.99% (net) for the reporting period vs. MSCI World Index that returned 3.12% for the same period. Contributors in the quarter were DSV, IQVIA Holdings and Samsung Electronics Pfd. Detractors in the quarter were Alibaba Group, CNH Industrial and Dassault Systemes.
Compagnie Lombard Odier SCmA lessened its stake in shares of IQVIA Holdings Inc. (NYSE: IQV) by 15.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 97,057 shares of the medical research company's stock after selling 17,275 shares during the period. Compagnie Lombard Odier
OPTIMAS CAPITAL Ltd purchased a new stake in shares of IQVIA Holdings Inc. (NYSE: IQV) in the third quarter, according to its most recent filing with the SEC. The firm purchased 21,100 shares of the medical research company's stock, valued at approximately $4,008,000. IQVIA accounts for about 2.5% of OPTIMAS CAPITAL Ltd's portfolio,
IQVIA (NYSE: IQV) executives said the company closed 2025 with a "strong" fourth quarter as revenue came in above the high end of management's guidance range and clinical demand indicators improved as the year progressed. On the company's fourth-quarter earnings call, management also introduced a simplified reporting structure for 2026, highlighted recent acquisitions and partnerships, and
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
IQVIA (NYSE: IQV - Get Free Report) and Xcorporeal (OTCMKTS:XCRP - Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Insider and Institutional Ownership 89.6% of IQVIA shares are held
Full Year Revenue Growth: 6%.Adjusted Diluted EPS Growth: 7%.Free Cash Flow: $2.1 billion, approximately 100% of adjusted net income.Fourth Quarter Revenue: $4